Pirbuterol

For other uses, see Maxair.

Pirbuterol

Systematic (IUPAC) name
(RS)-6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
Clinical data
Trade names	Maxair
AHFS/Drugs.com	Consumer Drug Information
MedlinePlus	a601096
Pregnancy category	C
Legal status	US: ℞-only
Routes of administration	Inhalational
Identifiers
CAS Number	38029-10-6 N
ATC code	R03AC08 R03CC07
PubChem	CID: 4845
IUPHAR/BPS	7272
DrugBank	DB01291 Y
ChemSpider	4679 Y
UNII	OG645J8RVW Y
KEGG	D08387 N
ChEMBL	CHEMBL1094966 Y
Chemical data
Formula	C12H20N2O3
Molecular mass	240.30 g/mol 300.3 g/mol (acetate)
SMILES Oc1ccc(nc1CO)C(O)CNC(C)(C)C
InChI InChI=1S/C12H20N2O3/c1-12(2,3)13-6-11(17)8-4-5-10(16)9(7-15)14-8/h4-5,11,13,15-17H,6-7H2,1-3H3 Y Key:VQDBNKDJNJQRDG-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Pirbuterol (trade name: Maxair) is a beta-2 adrenergic bronchodilator used in the treatment of asthma, available (as pirbuterol acetate) as a breath-activated metered-dose inhaler ("autohaler").

Clinical use

• Asthma - preventative/maintenance medicine
• Asthma - "rescue" medicine for reversal of acute asthma attack

Mode of action

Further information: Beta2-adrenergic agonist

Adverse effects

Further information: Beta2-adrenergic agonist

External links

• RxList: Maxair (Pirbuterol)